Drug recall · November 28, 2012
Dr. Reddy's Quetiapine Fumarate Tablets recall
Why: Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05
- Lots / codes
Lot C203090 Exp.03/14
- Quantity
- 1512 bottles
- Company
- Dr. Reddy's Laboratories, Inc., Bridgewater, NJ
- Distribution
- Nationwide. No foreign consignees.
- Initiated
- September 27, 2012 · Voluntary: Firm initiated
- Classified
- November 20, 2012
- Reported
- November 28, 2012
- Ended
- July 10, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Quetiapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.